Revising model for end-stage liver disease from calendar-time cross-sections with correction for selection bias
Eurotransplant liver transplant candidates are prioritized by Model for End-stage Liver Disease (MELD), a 90-day waitlist survival risk score based on the INR, creatinine and bilirubin. Several studies revised...
Source: BMC Medical Research Methodology - Category: Research Authors: H. C. de Ferrante, M. van Rosmalen, B. M. L. Smeulders, S. Vogelaar and F. C. R. Spieksma Tags: Research Source Type: research
More News: Bilirubin | Liver | Liver Disease | Liver Transplant | Research | Study | Transplant Surgery | Transplants | Urology & Nephrology